NEW YORK, Nov. 5 – Bruker Daltonics has agreed to develop a bench-top mass spectrometer to be integrated into a new Sequenom MassArray genotyping system for medium throughput analysis, the companies said Monday.
Under the terms of the deal Bruker Daltonics will develop a new GenoFlex system based on MALDI-TOF mass spectrometry. Sequenom currently uses a similar Bruker-based platform for its high-throughput MassArray system.
The companies did not disclose the financial terms or the deal or how much the new system would cost. The company has said previously that a high-throughput MassArray system costs between $400,000 and $1.1 million, depending on consumables.
Sequenom of San Diego said that it hoped the new system would help it to expand its customer base.
“We expect the addition of the GenoFlex MT to provide Sequenom with access to a broader market segment of customers which may be in the earlier stages of their ramp up in throughput requirements for genotyping, but are still interested in the features of our MassArray product line," Sequenom’s CEO Toni Schuh said in a statement.
Last week, Bruker Daltonics of Billerica, Mass., announced that it had agreed to work with Swedish proteomics company Biacore to develop a new proteomics system that would combine Biacore’s surface plasmon resonance technology with Bruker Daltonics mass spectrometry capabilities in a new platform to be known as SPR-MS.